Silo Pharma Inc (SILO) Stock Price, Quote & News

Company Profile

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders....

Industry: Biotechnology

Sector: Healthcare

Phone: 718 400 9031

Website: silopharma.com

Address:

677 North Washington Boulevard, Sarasota, United States

Money_Too_Long Dec. 23 at 3:44 PM

$SILO Well I’m out let’s see what’s next

0 · Reply

Money_Too_Long Dec. 22 at 6:31 PM

$SILO As soon as I start shorting this thing trying to edge up. 😬

0 · Reply

Money_Too_Long Dec. 19 at 6:36 PM

$SILO As soon as this dip to .30 I’m going big 🚀🚀🚀🚀🚀🚀NFA

0 · Reply

Money_Too_Long Dec. 18 at 9:34 PM

$SILO Almost time for seasonal stock rally Load Up NFA🚀🚀🚀🚀🚀

1 · Reply

CEOBuysDisclosures Dec. 17 at 1:40 AM

$SILO CEO purchased 5,000 shares at $0.41 for a total of $2,075. Weisblum Eric now owns 216,932 shares. https://ceo-buys.com

0 · Reply

Love_To_Learn Dec. 12 at 12:21 AM

$SILO need u soon

1 · Reply

Money_Too_Long Dec. 9 at 1:14 AM

$SILO This mf boiling ready to hit .85 and blast off.

1 · Reply

Money_Too_Long Dec. 8 at 8:27 PM

$SILO This thing ready to pop.

1 · Reply

TaySwift Dec. 3 at 8:13 PM

$SILO So: 🔹 No IND has been submitted yet. 🔹 IND-enabling data is still being generated. 🔹 The company itself is telling us: “we expect to submit in 2026” On Oct 24, 2025, shareholders approved giving the board power to do a reverse split between 1-for-2 and 1-for-20 any time before Oct 24, 2026, to help keep Nasdaq listing. $2.5M registered direct offering at $0.875 with attached warrants in Oct 2025. New 424B3 prospectus filed Nov 26, 2025 registering ~3.07M shares for resale by selling securityholders.

2 · Reply

MGeronimo Dec. 3 at 5:40 PM

$SILO AIF IT BREAKS .85 she will run up

1 · Reply

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

Oct 29, 2025, 8:25 AM EDT - 2 months ago

Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain

Oct 23, 2025, 8:45 AM EDT - 2 months ago

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Oct 8, 2025, 8:45 AM EDT - 2 months ago

Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth

Oct 6, 2025, 8:10 AM EDT - 2 months ago

Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)

Oct 1, 2025, 4:20 PM EDT - 3 months ago

Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 30, 2025, 8:02 AM EDT - 3 months ago

Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Sep 16, 2025, 8:11 AM EDT - 3 months ago

Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy

Sep 9, 2025, 9:10 AM EDT - 3 months ago

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

Sep 3, 2025, 8:25 AM EDT - 4 months ago

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio

Aug 21, 2025, 2:00 PM EDT - 4 months ago

Silo Pharma's Alzheimer's Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal

Aug 19, 2025, 8:05 AM EDT - 4 months ago

Silo Pharma's PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway

Aug 5, 2025, 8:32 AM EDT - 5 months ago

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Jul 16, 2025, 8:45 AM EDT - 5 months ago

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Jul 7, 2025, 8:15 AM EDT - 6 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Jun 25, 2025, 8:38 AM EDT - 6 months ago

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

Jun 25, 2025, 8:27 AM EDT - 6 months ago

Hoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.

HOTH

Jun 11, 2025, 9:00 AM EDT - 7 months ago

Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears

Jun 5, 2025, 9:15 AM EDT - 7 months ago

Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

May 21, 2025, 8:55 AM EDT - 7 months ago

Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 16, 2025, 4:15 PM EDT - 7 months ago

Silo Pharma Announces Closing of $2 Million Public Offering

May 15, 2025, 9:15 AM EDT - 8 months ago

Silo Pharma Announces Pricing of $2 Million Public Offering

May 14, 2025, 4:07 PM EDT - 8 months ago

Silo Pharma Selects Veloxity Labs for Bioanalytical IND-Enabling Study for our Novel Intranasal PTSD Therapy, SPC-15

May 14, 2025, 8:40 AM EDT - 8 months ago

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Apr 30, 2025, 8:11 AM EDT - 8 months ago

Silo Pharma's SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

Apr 28, 2025, 7:50 AM EDT - 8 months ago

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer's Drug

Mar 26, 2025, 8:40 AM EDT - 9 months ago

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

Feb 26, 2025, 1:30 PM EST - 10 months ago

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Feb 18, 2025, 8:50 AM EST - 11 months ago

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

Feb 11, 2025, 7:45 AM EST - 11 months ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Jan 22, 2025, 8:29 AM EST - 1 year ago

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Jan 2, 2025, 8:45 AM EST - 1 year ago

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Dec 18, 2024, 7:35 AM EST - 1 year ago

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia

Nov 29, 2024, 8:05 AM EST - 1 year ago

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Nov 18, 2024, 8:40 AM EST - 1 year ago

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Sep 10, 2024, 6:35 AM EDT - 1 year ago

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Aug 14, 2024, 2:30 PM EDT - 1 year ago

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Aug 7, 2024, 8:13 AM EDT - 1 year ago

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Jul 26, 2024, 8:20 AM EDT - 1 year ago

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Jul 22, 2024, 4:45 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 19, 2024, 8:01 AM EDT - 1 year ago

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 18, 2024, 12:44 PM EDT - 1 year ago

Silo Pharma Finds Partner For Device Development for Intranasal PTSD Drug

Jul 18, 2024, 8:25 AM EDT - 1 year ago

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Jul 16, 2024, 10:50 AM EDT - 1 year ago

Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?

Jul 16, 2024, 6:30 AM EDT - 1 year ago

Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic

Jun 26, 2024, 8:50 AM EDT - 1 year ago

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Jun 7, 2024, 8:18 AM EDT - 1 year ago

Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia

Jun 6, 2024, 4:50 PM EDT - 1 year ago

Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jun 4, 2024, 8:41 AM EDT - 1 year ago

Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety

Money_Too_Long Dec. 23 at 3:44 PM

$SILO Well I’m out let’s see what’s next

0 · Reply

Money_Too_Long Dec. 22 at 6:31 PM

$SILO As soon as I start shorting this thing trying to edge up. 😬

0 · Reply

Money_Too_Long Dec. 19 at 6:36 PM

$SILO As soon as this dip to .30 I’m going big 🚀🚀🚀🚀🚀🚀NFA

0 · Reply

Money_Too_Long Dec. 18 at 9:34 PM

$SILO Almost time for seasonal stock rally Load Up NFA🚀🚀🚀🚀🚀

1 · Reply

CEOBuysDisclosures Dec. 17 at 1:40 AM

$SILO CEO purchased 5,000 shares at $0.41 for a total of $2,075. Weisblum Eric now owns 216,932 shares. https://ceo-buys.com

0 · Reply

Love_To_Learn Dec. 12 at 12:21 AM

$SILO need u soon

1 · Reply

Money_Too_Long Dec. 9 at 1:14 AM

$SILO This mf boiling ready to hit .85 and blast off.

1 · Reply

Money_Too_Long Dec. 8 at 8:27 PM

$SILO This thing ready to pop.

1 · Reply

TaySwift Dec. 3 at 8:13 PM

2 · Reply

MGeronimo Dec. 3 at 5:40 PM

$SILO AIF IT BREAKS .85 she will run up

1 · Reply

MGeronimo Dec. 3 at 5:39 PM

$SILO going to run up

0 · Reply

Money_Too_Long Nov. 28 at 9:21 PM

$SILO Something is brewing.

1 · Reply

SlamminSammmy Nov. 27 at 4:19 PM

$SILO if crypto rallies in December this gonna keep climbing without news and when the news hits. Over 1 easy. Gobble gobble

0 · Reply

SPYmyQQQ Nov. 26 at 9:36 PM

🎯 Target Hit 🏁 📨 From Nov 24, 2025 💊 $SILO 💵 Entry: $0.3903 ✅ Ext: $0.4507 💰 P/L: +15.48% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

Money_Too_Long Nov. 26 at 2:22 PM

$SILO Seem like this is trying to take off.

1 · Reply

SPYmyQQQ Nov. 25 at 1:50 PM

🎯 Target Hit 🏁 📨 From Nov 21, 2025 💊 $SILO 💵 Entry: $0.3800 ✅ Ext: $0.4388 💰 P/L: +15.47% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

SPYmyQQQ Nov. 24 at 10:02 AM

🚀 New Signal ✅ 💊 $SILO 🗓️ Nov 24, 2025 💵 Entry: $0.3903 🎯 Target (Opt.): $0.4507 (+15.48%) 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

Jbjb90 Nov. 21 at 8:41 PM

$PBM my original position i was in at 4-5, when it pumped to 12 i held all the way through for some reason and have held since. I added at 1.52 earlier and added again just now at 1.48, this has to be the bottom 😡 pump this shit, low float and the news yesterday was good. Added this, $SILO and $ENSC off the lows. One of these is due for a jump. 💪

1 · Reply

Jbjb90 Nov. 21 at 8:15 PM

$SILO we have to be close to a bottom here, once news drops onwards and upwards 💪

1 · Reply

CEOBuysDisclosures Nov. 20 at 11:05 PM

$SILO CEO purchased 12,000 shares at $0.40 for a total of $4,847. Weisblum Eric now owns 209,932 shares. https://ceo-buys.com

0 · Reply

TaySwift Nov. 19 at 7:49 PM

$SILO do you think they'll do a reverse split here?

1 · Reply

TaySwift Nov. 18 at 5:57 PM

$SILO do they have to meet compliance by December?

1 · Reply

Market Cap	5.00M
Revenue (ttm)	70,000.00
Net Income (ttm)	-4.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6,271.43%
Debt to Equity Ratio	0.00

Volume	77,300
Avg Vol	344,944
Day's Range	N/A - N/A
Shares Out	13.32M
Stochastic %K	16%
Beta	0.36
Analysts	Strong Sell
Price Target	$10.00